Cargando…

CTLA-4 methylation regulates the pathogenesis of myasthenia gravis and the expression of related cytokines

BACKGROUND: Myasthenia gravis (MG) is a progressive autoimmune disease that occurs as a result of the failure of neuromuscular transmission and is characterized by muscle weakness. There has been evidence on the correlations between the genetic predisposition of cytotoxic T lymphocyte and the antige...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Ti-Kun, Yan, Cheng-Jun, Du, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393147/
https://www.ncbi.nlm.nih.gov/pubmed/29718870
http://dx.doi.org/10.1097/MD.0000000000010620
_version_ 1783398636523094016
author Fang, Ti-Kun
Yan, Cheng-Jun
Du, Juan
author_facet Fang, Ti-Kun
Yan, Cheng-Jun
Du, Juan
author_sort Fang, Ti-Kun
collection PubMed
description BACKGROUND: Myasthenia gravis (MG) is a progressive autoimmune disease that occurs as a result of the failure of neuromuscular transmission and is characterized by muscle weakness. There has been evidence on the correlations between the genetic predisposition of cytotoxic T lymphocyte and the antigen-4 (CTLA-4) and MG. Thus, the present study was conducted to study is designed to examine the effects of CTLA-4 methylation on the pathogenesis of MG and the expressions of related cytokines. METHODS: The CTLA-4 methylation levels in peripheral blood were quantified in 103 samples collected from MG patients and 86 samples from healthy individiuals. The expression of serum-related cytokines as well as the Treg cell ratio were examined so as to define the contributory role of CTLA-4 methylation in MG and to identify the interaction between CTLA-4 methylation and related factors, the expressions of DNA methyltransferase (DNMT)l, DNMT3A and DNMT3B, CTLA-4, AchR-Ab, Titin-Ab, RyR-Ab, IL-2, IL-10, IFN-γ, and TGF-β, activity of P- acetylcholinesterase (AchE) and E-AchE. RESULTS: The results indicated that the incidence of CTLA-4 methylation was significantly higher in the control group when compared with the MG group, and CTLA-4 methylation was also found to be associated with the thymus status of MG patients. It was also observed from the experiment data that the expressions of DNMTl, DNMT3A, and DNMT3B, along with the expressions of AchR-Ab, Titin-Ab, RyR-Ab, IL-2, IL-10, IFN-γ and TGF-β, and the activity of P-AchE and E-AchE were all higher in the MG group than in the control group, with a reduction of CTLA-4 expression. Another key finding from this study revealed that methylation interference can lead to the suppression in the expression of AchR-Ab, the activity of E-AchE, the expression of IL-2, IL-10, IFN-γ, and TGF-β and the Treg cell ratio in lymphocytes. CONCLUSION: In conclusion, the results obtained from the present study highly indicated that CTLA-4 methylation might play a role in facilitating the occurrence of MG and increasing the expressions of related cytokines through the upregulation of AchR-Ab and E-Ach.
format Online
Article
Text
id pubmed-6393147
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-63931472019-03-15 CTLA-4 methylation regulates the pathogenesis of myasthenia gravis and the expression of related cytokines Fang, Ti-Kun Yan, Cheng-Jun Du, Juan Medicine (Baltimore) Research Article BACKGROUND: Myasthenia gravis (MG) is a progressive autoimmune disease that occurs as a result of the failure of neuromuscular transmission and is characterized by muscle weakness. There has been evidence on the correlations between the genetic predisposition of cytotoxic T lymphocyte and the antigen-4 (CTLA-4) and MG. Thus, the present study was conducted to study is designed to examine the effects of CTLA-4 methylation on the pathogenesis of MG and the expressions of related cytokines. METHODS: The CTLA-4 methylation levels in peripheral blood were quantified in 103 samples collected from MG patients and 86 samples from healthy individiuals. The expression of serum-related cytokines as well as the Treg cell ratio were examined so as to define the contributory role of CTLA-4 methylation in MG and to identify the interaction between CTLA-4 methylation and related factors, the expressions of DNA methyltransferase (DNMT)l, DNMT3A and DNMT3B, CTLA-4, AchR-Ab, Titin-Ab, RyR-Ab, IL-2, IL-10, IFN-γ, and TGF-β, activity of P- acetylcholinesterase (AchE) and E-AchE. RESULTS: The results indicated that the incidence of CTLA-4 methylation was significantly higher in the control group when compared with the MG group, and CTLA-4 methylation was also found to be associated with the thymus status of MG patients. It was also observed from the experiment data that the expressions of DNMTl, DNMT3A, and DNMT3B, along with the expressions of AchR-Ab, Titin-Ab, RyR-Ab, IL-2, IL-10, IFN-γ and TGF-β, and the activity of P-AchE and E-AchE were all higher in the MG group than in the control group, with a reduction of CTLA-4 expression. Another key finding from this study revealed that methylation interference can lead to the suppression in the expression of AchR-Ab, the activity of E-AchE, the expression of IL-2, IL-10, IFN-γ, and TGF-β and the Treg cell ratio in lymphocytes. CONCLUSION: In conclusion, the results obtained from the present study highly indicated that CTLA-4 methylation might play a role in facilitating the occurrence of MG and increasing the expressions of related cytokines through the upregulation of AchR-Ab and E-Ach. Wolters Kluwer Health 2018-05-04 /pmc/articles/PMC6393147/ /pubmed/29718870 http://dx.doi.org/10.1097/MD.0000000000010620 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Research Article
Fang, Ti-Kun
Yan, Cheng-Jun
Du, Juan
CTLA-4 methylation regulates the pathogenesis of myasthenia gravis and the expression of related cytokines
title CTLA-4 methylation regulates the pathogenesis of myasthenia gravis and the expression of related cytokines
title_full CTLA-4 methylation regulates the pathogenesis of myasthenia gravis and the expression of related cytokines
title_fullStr CTLA-4 methylation regulates the pathogenesis of myasthenia gravis and the expression of related cytokines
title_full_unstemmed CTLA-4 methylation regulates the pathogenesis of myasthenia gravis and the expression of related cytokines
title_short CTLA-4 methylation regulates the pathogenesis of myasthenia gravis and the expression of related cytokines
title_sort ctla-4 methylation regulates the pathogenesis of myasthenia gravis and the expression of related cytokines
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393147/
https://www.ncbi.nlm.nih.gov/pubmed/29718870
http://dx.doi.org/10.1097/MD.0000000000010620
work_keys_str_mv AT fangtikun ctla4methylationregulatesthepathogenesisofmyastheniagravisandtheexpressionofrelatedcytokines
AT yanchengjun ctla4methylationregulatesthepathogenesisofmyastheniagravisandtheexpressionofrelatedcytokines
AT dujuan ctla4methylationregulatesthepathogenesisofmyastheniagravisandtheexpressionofrelatedcytokines